Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 80174 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
XW043NA
|
Introduction of Tarlatamab-dlle Antineoplastic into Central Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043P9
|
Introduction of Glofitamab Antineoplastic into Central Vein Percutaneous Approach New Technology Group 9
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043PB
|
Introduction of Aztreonam-avibactam Anti-infective into Central Vein Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043Q5
|
Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein Percutaneous Approach New Technology Group 5
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043Q9
|
Introduction of Posoleucel into Central Vein Percutaneous Approach New Technology Group 9
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043QB
|
Introduction of Iloprost into Central Vein Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043R9
|
Introduction of Rezafungin into Central Vein Percutaneous Approach New Technology Group 9
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043RB
|
Introduction of Letetresgene Autoleucel into Central Vein Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043S5
|
Introduction of Iobenguane I-131 Antineoplastic into Central Vein Percutaneous Approach New Technology Group 5
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043W5
|
Introduction of Caplacizumab into Central Vein Percutaneous Approach New Technology Group 5
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW043WB
|
Introduction of Fosfomycin Anti-infective into Central Vein Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0534B
|
Introduction of Somatic Stem Cells into Peripheral Artery Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW053T9
|
Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery Percutaneous Approach New Technology Group 9
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0632B
|
Introduction of CPI-601 Enzyme Replacement Therapy into Cerebral Ventricle Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0DX38
|
Introduction of Maribavir Anti-infective into Mouth and Pharynx External Approach New Technology Group 8
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0DX82
|
Introduction of Uridine Triacetate into Mouth and Pharynx External Approach New Technology Group 2
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0DXF5
|
Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx External Approach New Technology Group 5
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0DXJ9
|
Introduction of Quizartinib Antineoplastic into Mouth and Pharynx External Approach New Technology Group 9
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0DXK8
|
Introduction of Sabizabulin into Mouth and Pharynx External Approach New Technology Group 8
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0DXM6
|
Introduction of Baricitinib into Mouth and Pharynx External Approach New Technology Group 6
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.